These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 999549)

  • 21. Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the ocular hypertension treatment study.
    Piltz J; Gross R; Shin DH; Beiser JA; Dorr DA; Kass MA; Gordon MO
    Am J Ophthalmol; 2000 Oct; 130(4):441-53. PubMed ID: 11024416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of topical anesthesia on tonometric values of intraocular pressure.
    Baudouin C; Gastaud P
    Ophthalmologica; 1994; 208(6):309-13. PubMed ID: 7845645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 8-iso prostaglandin E2 on aqueous humor dynamics in monkeys.
    Wang RF; Lee PY; Mittag TW; Podos SM; Serle JB; Becker B
    Arch Ophthalmol; 1998 Sep; 116(9):1213-6. PubMed ID: 9747682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced ocular hypotensive response to epinephrine with prior dexamethasone treatment.
    Bealka N; Schwartz B
    Arch Ophthalmol; 1991 Mar; 109(3):346-8. PubMed ID: 2003792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open-angle glaucoma.
    Lewis JM; Priddy T; Judd J; Gordon MO; Kass MA; Kolker AE; Becker B
    Am J Ophthalmol; 1988 Nov; 106(5):607-12. PubMed ID: 3189477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corneal endothelial changes with long-term topical epinephrine therapy.
    Waltman SR; Yarian D; Hart W; Becker B
    Arch Ophthalmol; 1977 Aug; 95(8):1357-8. PubMed ID: 889507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical sympathectomy with 6-hydroxydopamine in the treatment of primary open-angle glaucoma.
    Kitazawa Y; Nosé H; Horie T
    Am J Ophthalmol; 1975 Jan; 79(1):98-103. PubMed ID: 1110209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A combination of 1% guanethidine and 0.2% epinephrine in drop form to lower IOP in open-angle glaucoma (author's transl)].
    van Husen H
    Klin Monbl Augenheilkd; 1980 Nov; 177(5):622-7. PubMed ID: 7253518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose epinephrine.
    Obstbaum SA; Kolker AE; Phelps CD
    Arch Ophthalmol; 1974 Aug; 92(2):118-20. PubMed ID: 4847502
    [No Abstract]   [Full Text] [Related]  

  • 30. Contributions of adenosine receptor activation to the ocular actions of epinephrine.
    Crosson CE; Petrovich M
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2054-61. PubMed ID: 10440261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simplified test of epinephrine responsiveness.
    Kass MA; Becker B
    Arch Ophthalmol; 1978 Jun; 96(6):999-1000. PubMed ID: 655950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular hypotensive effects of anti-glaucoma agents in mice.
    Akaishi T; Odani-Kawabata N; Ishida N; Nakamura M
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):401-8. PubMed ID: 19857101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
    Denis P; Lafuma A; Khoshnood B; Mimaud V; Berdeaux G
    Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group.
    Silver LH
    Am J Ophthalmol; 1998 Sep; 126(3):400-8. PubMed ID: 9744373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraocular pressure changes in the contralateral eye after trabeculectomy with mitomycin C.
    Vysniauskiene I; Shaarawy T; Flammer J; Haefliger IO
    Br J Ophthalmol; 2005 Jul; 89(7):809-11. PubMed ID: 15965155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of topical travoprost 0.004% on intraocular pressure and corneal biomechanical properties in an animal model.
    Lazcano-Gomez G; Ancona-Lezama D; Gil-Carrasco F; Jimenez-Roman J
    Digit J Ophthalmol; 2016; 22(1):1-5. PubMed ID: 27330476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Ocular Hypotensive Efficacy of Topical Fasudil, a Rho-Associated Protein Kinase Inhibitor, in Patients With End-Stage Glaucoma.
    Pakravan M; Beni AN; Ghahari E; Varshochian R; Yazdani S; Esfandiari H; Ahmadieh H
    Am J Ther; 2017; 24(6):e676-e680. PubMed ID: 26825486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose response of dexamethasone for the enhanced ocular hypotensive response to epinephrine in rabbits with prior dexamethasone treatment.
    Schwartz B; Rom ME; Bealka N; Qi Y
    J Ocul Pharmacol Ther; 2002 Apr; 18(2):133-9. PubMed ID: 12002667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraocular pressure effects of multiple doses of drugs applied to glaucomatous monkey eyes.
    Lee PY; Podos SM; Serle JB; Camras CB; Severin CH
    Arch Ophthalmol; 1987 Feb; 105(2):249-52. PubMed ID: 3813959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical studies conducted with a new epinephrine derivative for the treatment of glaucoma (Dipivalyl epinephrine)].
    Bischoff P
    Klin Monbl Augenheilkd; 1978 Apr; 172(4):565-8. PubMed ID: 349251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.